BioSpace News Archive

Palisade Bio, Inc. today announced the promotion of Robert McRae to Chief Operating Officer.

Summit Healthcare Acquisition Corp. and YishengBio Co., Ltd announced that the Securities and Exchange Commission has declared the effectiveness of YS Biopharma’s registration statement on Form F-4 in connection with the previously announced proposed business combination between Summit and YS Biopharma, on February 7, 2023.

Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat metastatic breast and gynecological cancers harboring ESR1 mutations, today announced that it had an abstract accepted as a Discussed E-poster Presentation at the International Society for the Study of Women’s Sexual Health (ISSWSH) Annual Meeting 2023.

BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage company focused on stem cell-based therapies, today announced that the European Patent Office has issued a notice of allowance for a patent application related to the Company’s metabolic ThermoStem® program.

Paragonix Technologies, Inc., a leading organ preservation provider, announced today a pioneering lung transplantation case in which donor lungs procured overnight were preserved with the LUNGguard Donor Lung Preservation System, allowing for next day transplant surgery led by Prof. Dr. Laurens Ceulemans at UZ Leuven in Belgium.

OcuSciences, a medical device company developing ocular imagers to detect early disease by assessing retinal metabolic activity, today announced the publication of an Age-related Macular Degeneration (AMD) study in the Ophthalmic Surgery, Lasers and Imaging Retina journal.

The Mark Foundation for Cancer Research announced the latest recipients of its Drug Discovery Award, a program designed to accelerate the trajectory of converting promising scientific discoveries into therapeutics that will benefit cancer patients.

Boston Imaging, the United States headquarters of Samsung’s digital radiography and ultrasound business, introduces the HERA W10 Elite1; the premier model of the HERA platform for Obstetrics and Gynecology that provides clinicians with a suite of powerful artificial intelligence tools and clinical applications to advance the diagnostic experience.

Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that its first NovaSeq X Plus system was recently delivered to the Broad Institute.

Nurix Therapeutics, Inc. announced that Arthur T. Sands, M.D., Ph.D., Nurix’s president and chief executive officer, and Gwenn M. Hansen, Ph.D., Nurix’s chief scientific officer, will participate in the following conferences in February.